UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel

Phase 1

Completed

Conditions: Contraception

Interventions: Drug: Nestorone gel
Drug: Testosterone Gel

First Posted Date: 2005-09-29

Last Posted Date: 2014-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 140

Registration Number: NCT00229593

Locations: 🇺🇸
Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine

Phase 1

Completed

Conditions: Recurrent Breast Cancer
Stage IV Ovarian Epithelial Cancer
Recurrent Non-small Cell Lung Cancer
Stage IV Breast Cancer
HER2-positive Breast Cancer
Recurrent Ovarian Germ Cell Tumor
Recurrent Ovarian Epithelial Cancer
Stage IV Non-small Cell Lung Cancer
Stage IV Ovarian Germ Cell Tumor

Interventions: Drug: ex vivo-expanded HER2-specific T cells
Biological: denileukin diftitox
Drug: cyclophosphamide
Other: flow cytometry
Other: immunoenzyme technique

First Posted Date: 2005-09-28

Last Posted Date: 2014-11-11

Lead Sponsor: University of Washington

Target Recruit Count: 8

Registration Number: NCT00228358

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: cisplatin
Drug: pemetrexed disodium
Procedure: adjuvant therapy
Procedure: therapeutic conventional surgery
Radiation: fludeoxyglucose F 18

First Posted Date: 2005-09-28

Last Posted Date: 2017-05-09

Lead Sponsor: University of Washington

Target Recruit Count: 25

Registration Number: NCT00227539

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States
🇺🇸
University of Washington School of Medicine, Seattle, Washington, United States

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Flutamide
Drug: Leuprolide Acetate

First Posted Date: 2005-09-22

Last Posted Date: 2018-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 102

Registration Number: NCT00223665

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan Children

Phase 2

Completed

Conditions: HIV Infections

Interventions: Behavioral: Medication diaries

First Posted Date: 2005-09-19

Last Posted Date: 2012-07-09

Lead Sponsor: University of Washington

Target Recruit Count: 100

Registration Number: NCT00194545

Locations: 🇰🇪
University of Nairobi, Nairobi, Kenya

Cyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at Home

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

First Posted Date: 2005-09-19

Last Posted Date: 2006-04-14

Lead Sponsor: University of Washington

Target Recruit Count: 82

Registration Number: NCT00194506

Locations: 🇺🇸
University of Washington, General Internal Medicine Clinic, Roosevelt, Seattle, Washington, United States

Botox as a Treatment for Interstitial Cystitis in Women

Phase 4

Completed

Conditions: Painful Bladder Syndrome
Interstitial Cystitis

Interventions: Other: normal saline
Drug: Botox

First Posted Date: 2005-09-19

Last Posted Date: 2012-10-12

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00194610

Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasm

Interventions: Drug: Vinorelbine
Drug: Capecitabine

First Posted Date: 2005-09-19

Last Posted Date: 2012-09-13

Lead Sponsor: University of Washington

Target Recruit Count: 40

Registration Number: NCT00194727

Locations: 🇺🇸
University of Washington; Seattle Cancer Care Alliance, Seattle, Washington, United States

Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

Phase 2

Completed

Conditions: Breast Neoplasm

Interventions: Drug: Paclitaxel
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: G-CSF

First Posted Date: 2005-09-19

Last Posted Date: 2012-09-13

Lead Sponsor: University of Washington

Target Recruit Count: 80

Registration Number: NCT00194753

Locations: 🇺🇸
University of Washington/Seattle Cancer Care Alliance, Seattle, Washington, United States

TRADE-Testosterone Replacement and Dutasteride Effectiveness

Phase 4

Completed

Conditions: Hypogonadism
Benign Prostatic Hyperplasia

Interventions: Drug: Dutasteride
Drug: Testosterone gel
Drug: Placebo dutasteride

First Posted Date: 2005-09-19

Last Posted Date: 2017-12-05

Lead Sponsor: University of Washington

Target Recruit Count: 53

Registration Number: NCT00194675

Locations: 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy